JCO is the primary forum of scientific discourse for the American Society of Clinical Oncology (ASCO). Published three times a month, JCO is the foremost peer-reviewed journal focusing on clinical ...

ASCO Journals have adopted a format-free submission policy (EZSubmit). New submissions are not scrutinized for compliance with our formatting guidelines (reference style, order of components, figure ...

Jonathan W. Friedberg, MD, University of Rochester, Rochester, NY, USA ...

JCO Journals employ a single-blind review process. Reviewers know the identity of the authors, but authors do not know the identity of the reviewers. Approximately 1/3 of submissions are rejected ...

JCO Journals have adopted a format-free submission policy (EZSubmit). New submissions are not scrutinized for compliance with our formatting guidelines (reference style, order of components, figure ...

All content dealing with understanding the provision of care—the mechanics of practice, care delivery, quality improvement, value, and equity—is the purview of JCO OP. JCO OP also addresses an ...

Real-World Tolerability of Capecitabine and Oxaliplatin in Patients in the United States With Localized Colorectal Cancer Undergoing Curative-Intent Treatment Because of a lack of evidence-based ...

The 2024 ASCO Annual Meeting Proceedings – Head and Neck Cancer Abstracts Edition is a listing of all accepted abstracts from the head and neck cancer track of the 2024 ASCO Annual Meeting.

Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3 ...

To wrap up 2024, we proudly present the Top 5 articles from each JCO Journal. The editors and staff are grateful to all of our authors for choosing JCO Journals to publish their work. Meric-Bernstam ...

Despite recent momentum in the field, the treatment of patients with uCRLM remains heterogeneous and center-dependent. In the United States (US), few transplant centers offer protocols, and multimodal ...